Medicare Enrolled

Dr. Selena Ellis, MD

Neurology · Berkeley, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3000 COLBY ST STE 302, Berkeley, CA 94705
5106442282
In practice since 2006 (20 years)
NPI: 1265412993 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ellis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ellis? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ellis

Dr. Selena Ellis is a neurology specialist in Berkeley, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ellis performed 9,665 Medicare services across 693 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ellis received a total of $3,256 from 26 pharmaceutical and/or device companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ellis is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 10% volume in CA $3,256 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,665
Medicare services
Top 10% in CA for neurology
693
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~483 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
8,400 $5 $8
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
528 $110 $225
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
284 $99 $160
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
140 $201 $580
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
107 $84 $200
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
71 $59 $250
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
45 $136 $300
Injection of anesthetic or steroid into upper neck and back of head nerve
An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head.
31 $48 $300
Injection of anesthetic agent and/or steroid into other nerve or branch 31 $107 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
28 $136 $360
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$3,256
Total received (2018-2024)
Avg $465/year across 7 years
Top 38% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
163
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,256 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$842
2023
$475
2022
$531
2021
$546
2020
$557
2019
$112
2018
$194

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$261
Alexion Pharmaceuticals, Inc.
$122
PFIZER INC.
$82
ARGENX US, INC.
$74
Teva Pharmaceuticals USA, Inc.
$65
SCILEX PHARMACEUTICALS INC.
$52
Alnylam Pharmaceuticals Inc.
$49
MITSUBISHI TANABE PHARMA AMERICA, INC.
$43
Lilly USA, LLC
$29
Otsuka America Pharmaceutical, Inc.
$24
Eisai Inc.
$21
Octapharma USA, Inc.
$21
Top 3 companies account for 55.2% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$511
ABBVIE INC.
$388
IMPEL PHARMACEUTICALS INC.
$383
Alexion Pharmaceuticals, Inc.
$271
Teva Pharmaceuticals USA, Inc.
$221
AbbVie Inc.
$198
Lilly USA, LLC
$178
Amgen Inc.
$148
Allergan Inc.
$117
UPSHER-SMITH LABORATORIES LLC
$102
Biohaven Pharmaceuticals, Inc.
$97
PFIZER INC.
$82
ARGENX US, INC.
$74
MITSUBISHI TANABE PHARMA AMERICA, INC.
$71
Biohaven Pharmaceutical Holding Company Ltd.
$58
Lundbeck LLC
$56
SCILEX PHARMACEUTICALS INC.
$52
Alnylam Pharmaceuticals Inc.
$49
Octapharma USA, Inc.
$42
Scilex Pharmaceuticals Inc.
$32
Otsuka America Pharmaceutical, Inc.
$24
Merz Pharmaceuticals, LLC
$22
Upsher-Smith Laboratories LLC
$22
Eisai Inc.
$21
Medtronic USA, Inc.
$20
Neurocrine Biosciences, Inc.
$18
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
ACTIVA · AJOVY · AMVUTTRA · AUSTEDO · Aimovig · BOTOX · BOTOX COSMETIC · ELYXYB · ELYXYB - CELECOXIB · EMGALITY · INGREZZA · Leqembi · NUEDEXTA · NURTEC ODT · PANZYGA · QULIPTA · RADICAVA · REYVOW · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · Trudhesa · UBRELVY · ULTOMIRIS · VYEPTI · VYVGART HYTRULO · Xeomin · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology specialist in Berkeley?
Compare neurologists in the Berkeley area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
253
Per 100K population
15.3
County median income
$126,240
Nearest hospital
ALTA BATES SUMMIT MEDICAL CENTER - ALTA BATES CAMP
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ellis is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ellis experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Ellis performed 8,400 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ellis receive payments from pharmaceutical companies?
Yes. Dr. Ellis received a total of $3,256 from 26 companies across 163 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ellis's costs compare to other neurologists in Berkeley?
Dr. Ellis's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ellis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →